CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine tested to stop skin Cancer's return
Disease control CompletedThis study tested a personalized mRNA vaccine combined with an immunotherapy drug for people with advanced skin cancer that could be removed by surgery. The goal was to see if giving this combination before and after surgery was better than standard care at keeping the cancer fro…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope to stop aggressive skin Cancer's return
Disease control CompletedThis study tested whether a drug called pembrolizumab could help prevent a serious type of skin cancer from coming back after surgery and radiation. It involved 450 people with high-risk, locally advanced skin cancer who had completed their initial treatment. The main goal was to…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Cancer trial aims to reduce harsh radiation side effects
Disease control CompletedThis study tested whether using lower radiation doses to healthy neck lymph nodes could reduce long-term side effects while still preventing cancer recurrence. It involved 300 adults with head and neck cancer who were scheduled for curative radiation treatment. Researchers compar…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC